BEST UNLIMITED TURBO SHORT CERTIFICATE - ELI LILLY & CO | Market Closed - Borsa Italiana 04:04:59 2024-07-12 pm EDT | ||
| 7.56 EUR | -14.29% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 7.85 | -11.00% |
| 24-07-11 | 8.82 | +1.85% |
| 24-07-10 | 8.66 | -4.63% |
| 24-07-09 | 9.08 | -14.18% |
| 24-07-08 | 10.58 | -1.76% |
Real-time Borsa Italiana
Last update July 12, 2024 at 04:04 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| S36848 | |
| ISIN | DE000SY2D4B1 |
| Date issued | 2024-07-02 |
| Strike | 1,027 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.98 € |
|---|---|
| Lowest since issue | 7.56 € |
| Spread | 0.12 € |
| Spread % | 1.56% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
948.4
USD
Average target price
894.8
USD
Spread / Average Target
-5.65%
- Stock Market
- Certificates
- S36848 Certificat
